tiprankstipranks
Ivy Cosmetics Corporation (JP:4918)
:4918
Japanese Market

Ivy Cosmetics Corporation (4918) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4918

Ivy Cosmetics Corporation

(4918)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
¥354.00
▲(4.42% Upside)
Action:ReiteratedDate:03/24/26
The score is held up by improved financial footing and strong recent cash generation, but is pressured by weak technical momentum and valuation signals tied to loss-making/volatile earnings.
Positive Factors
Deleveraged Balance Sheet
The dramatic fall in debt-to-equity to ~0.09 materially de-risks the capital structure, lowering interest exposure and increasing financial flexibility. This durability supports investment, working capital resilience and optionality in downturns while management rebuilds earnings over time.
Negative Factors
Volatile Profitability
Large swings from deep losses to modest profits and a steep net margin decline show earnings are highly cyclical or exposed to one-off costs. This volatility undermines predictability of long-term returns and complicates capital allocation, budgeting and investor confidence.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraged Balance Sheet
The dramatic fall in debt-to-equity to ~0.09 materially de-risks the capital structure, lowering interest exposure and increasing financial flexibility. This durability supports investment, working capital resilience and optionality in downturns while management rebuilds earnings over time.
Read all positive factors

Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)

Ivy Cosmetics Corporation Business Overview & Revenue Model

Company Description
Ivy Cosmetics Corporation manufactures and sells cosmetics and beauty supplement products. The company offers penetrating beauty liquid, lotion/emulsion/cream, and cleansing/face wash products. It also offers optional care, makeup, hair care, and ...

Ivy Cosmetics Corporation Financial Statement Overview

Summary
Balance sheet and cash flow are relatively strong (lower leverage with debt-to-equity ~0.09, and solid FY2025 operating/free cash flow), but earnings quality is weakened by unstable profitability (net margin ~1.5% in FY2025 vs ~5.9% in FY2024 and a large loss in FY2023).
Income Statement
45
Neutral
Balance Sheet
68
Positive
Cash Flow
72
Positive
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.93B2.71B2.94B3.53B3.43B
Gross Profit2.07B1.91B2.11B2.42B2.14B
EBITDA20.62M242.60M-33.16M185.13M255.05M
Net Income43.01M160.31M-384.61M40.38M-23.23M
Balance Sheet
Total Assets3.57B3.57B3.85B4.49B4.86B
Cash, Cash Equivalents and Short-Term Investments577.94M208.73M247.67M129.38M113.43M
Total Debt211.34M451.69M1.05B1.18B1.79B
Total Liabilities1.10B1.33B1.87B2.22B3.35B
Stockholders Equity2.47B2.24B1.98B2.27B1.51B
Cash Flow
Free Cash Flow424.68M408.70M243.33M-160.58M374.53M
Operating Cash Flow445.94M453.06M278.59M-107.06M427.02M
Investing Cash Flow-18.43M7.30M-29.30M63.30M330.37M
Financing Cash Flow-58.27M-499.31M-131.00M59.71M-693.39M

Ivy Cosmetics Corporation Technical Analysis

Technical Analysis Sentiment
Negative
Last Price339.00
Price Trends
50DMA
390.38
Negative
100DMA
364.12
Negative
200DMA
346.67
Positive
Market Momentum
MACD
-6.33
Positive
RSI
33.90
Neutral
STOCH
35.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Negative. The current price of 339 is below the 20-day moving average (MA) of 393.05, below the 50-day MA of 390.38, and below the 200-day MA of 346.67, indicating a neutral trend. The MACD of -6.33 indicates Positive momentum. The RSI at 33.90 is Neutral, neither overbought nor oversold. The STOCH value of 35.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4918.

Ivy Cosmetics Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
¥6.83B12.522.38%-0.79%
68
Neutral
¥2.17B3.431.72%-6.06%-97.12%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
¥5.73B-33.121.68%8.46%
56
Neutral
¥6.09B8.181.59%-9.99%-35.06%
52
Neutral
¥5.36B42.42-19.42%
51
Neutral
¥2.07B-3.0412.96%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4918
Ivy Cosmetics Corporation
365.00
117.00
47.18%
JP:4920
Nippon Shikizai, Inc.
1,033.00
-84.85
-7.59%
JP:4925
HABA Laboratories, Inc.
1,805.00
-23.70
-1.30%
JP:4926
C'BON COSMETICS Co., Ltd.
1,339.00
160.80
13.65%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
758.00
-34.21
-4.32%
JP:4934
Premier Anti-Aging Co., Ltd.
615.00
-262.00
-29.87%

Ivy Cosmetics Corporation Corporate Events

Ivy Cosmetics Swings Back to Profit on Higher Margins Despite Softer Sales
Feb 10, 2026
Ivy Cosmetics reported net sales of ¥1.70 billion for the quarter ended December 2025, a slight 1.8% decline from a year earlier, but significantly improved profitability, with operating profit nearly doubling to ¥33 million and ordinary...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026